Connor, Clark & Lunn Investment Management (CC&L)’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-87,550
Closed -$273K 1590
2023
Q2
$273K Buy
+87,550
New +$273K ﹤0.01% 1126